{"filing":{"accession_number":"0001213900-26-096962","cik":"0002032341","ticker":"CYAB","company_name":"CYABRA, INC.","form":"8-K","filing_date":"2026-09-03","report_date":"2026-09-02","primary_document":"ea0304485-8k_cyabra.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2032341/000121390026096962/ea0304485-8k_cyabra.htm"},"events":[{"id":31513,"run_id":28919,"accession_number":"0001213900-26-096962","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Stockholders approved two material proposals at a Special Meeting: (1) authorization of share issuance exceeding 20% of outstanding Common Stock in connection with a Private Placement and conversion agreements, and (2) amendment to the 2026 Omnibus Equity Incentive Plan increasing the share reserve from 2,072,125 to 22,072,125 shares with an annual 15% adjustment mechanism. Both proposals passed with strong majorities.","company_name":"CYABRA, INC.","ticker":"CYAB","filing_date":"2026-09-03","form":"8-K","submitted_at":null,"items":[{"id":34431,"accession_number":"0001213900-26-096962","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2026 Omnibus Equity Incentive Plan, which increases the share reserve from 2,072,125 to 22,072,125 shares and establishes an annual increase mechanism tied to 15% of fully diluted capitalization. This is a compensatory arrangement affecting equity grants available to officers and directors, fitting the exec_compensation category under Item 5.02(e). The material increase in share authorization and the ongoing annual adjustment mechanism would affect investor assessment of dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T13:11:56.153829+00:00","company_name":"","ticker":null,"filing_date":""},{"id":34432,"accession_number":"0001213900-26-096962","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from a Special Meeting of stockholders on two material proposals: (1) approval of share issuance in excess of 20% of outstanding Common Stock in connection with a Private Placement and conversion agreements, and (2) approval of a 2026 Plan amendment increasing the share reserve by 20 million shares plus an annual 15% adjustment. Both proposals passed with strong majorities and directly affect shareholder dilution and equity compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T13:11:56.153829+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34431,"accession_number":"0001213900-26-096962","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2026 Omnibus Equity Incentive Plan, which increases the share reserve from 2,072,125 to 22,072,125 shares and establishes an annual increase mechanism tied to 15% of fully diluted capitalization. This is a compensatory arrangement affecting equity grants available to officers and directors, fitting the exec_compensation category under Item 5.02(e). The material increase in share authorization and the ongoing annual adjustment mechanism would affect investor assessment of dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T13:11:56.153829+00:00","company_name":"CYABRA, INC.","ticker":"CYAB","filing_date":"2026-09-03"},{"id":34432,"accession_number":"0001213900-26-096962","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from a Special Meeting of stockholders on two material proposals: (1) approval of share issuance in excess of 20% of outstanding Common Stock in connection with a Private Placement and conversion agreements, and (2) approval of a 2026 Plan amendment increasing the share reserve by 20 million shares plus an annual 15% adjustment. Both proposals passed with strong majorities and directly affect shareholder dilution and equity compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-03T13:11:56.153829+00:00","company_name":"CYABRA, INC.","ticker":"CYAB","filing_date":"2026-09-03"}]}